SCHEMBL3557656

SCHEMBL3557656

Cc1cccc(S(=O)(=O)Nc2cccc(CCc3ccccc3C(=O)O)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
AKR1C3 P42330 1/20 0.51
ALPL P05186 1/20 0.49
ALPI P09923 1/20 0.49
ALPG P10696 1/20 0.49
LIMK1 P53667 1/20 0.49
LIMK2 P53671 1/20 0.49
ALDH1A1 P00352 2/20 0.49
SLC16A3 O15427 2/20 0.48
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
MAPK1 P28482 1/20 0.47
PFKFB3 Q16875 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3561338 0.91 HTR6 (0.62) HTR6ALDH1A1SLC16A3KEAP1NFE2L2
SCHEMBL3554799 0.90 ALDH1A1 (0.55) HTR6MEN1KMT2AAKR1C3ALDH1A1
SCHEMBL3556527 0.90 ALDH1A1 (0.56) HTR6MEN1KMT2ALIMK1LIMK2
SCHEMBL3559120 0.87 SLC16A3 (0.54) HTR6MEN1KMT2ALIMK2SLC16A3
SCHEMBL3561858 0.86 MEN1 (0.65) HTR6MEN1KMT2AAKR1C3LIMK1
SCHEMBL3563734 0.86 AKR1C3 (0.53) HTR6MEN1KMT2AAKR1C3ALPL
SCHEMBL3561354 0.85 ALDH1A1 (0.58) HTR6MEN1KMT2AALDH1A1SLC16A3
SCHEMBL3557572 0.85 SLC16A3 (0.67) HTR6MEN1KMT2AAKR1C3ALDH1A1
SCHEMBL3562226 0.85 ALDH1A1 (0.58) HTR6MEN1KMT2ALIMK2ALDH1A1
SCHEMBL3556251 0.85 TSHR (0.48) HTR6MEN1KMT2ASLC16A3KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 HTR6 2387/4885MEN1 2548/4885KMT2A 4045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.